Fierce Pharma Biopharma News Insights Fierce Pharma delivers breaking news and analysis about drug companies, the FDA and the broader pharma industry, including manufacturing, marketing and finance
JPM26, Day 1: BMS CEO touts portfolio of blockbuster hopefuls After a flurry of Big Pharma deals in the first week of the new year, the life sciences industry is heading to San Francisco for the industry's big | After a flurry of Big Pharma deals in the
Pharma | Fierce Pharma With a new nod in ovarian cancer, Corcept has redeemed its lead asset relacorilant after stumbling in a separate indication late last year
Pharmaceuticals tariff to come in next month or two: Lutnick Despite President Donald Trump’s threat last week that tariffs on pharmaceuticals will come “very shortly,” the biopharma industry may have a brief reprieve after all—that’s if a new